Globe Newswire10.24.17
Amedica Corporation, a biomaterial company that develops and manufactures silicon nitride as a platform for biomedical applications, announced key podium presentations to be made and its participation at the annual meeting of the North American Spine Society (NASS) this week in Orlando, Fla. At the 2017 NASS annual meeting spine care professionals from around the globe will share the latest information, innovative techniques and procedures, best practices, and new technologies.
Amedica has had three podium presentations accepted by NASS that will be delivered by surgeon users of Amedica’s silicon nitride products. These presentations reflect the scientific and clinical advancements of Amedica’s innovative silicon nitride material. More specifically, the presentations will demonstrate silicon nitride’s innate bioactivity, osseoconductivity, and inherent antimicrobial properties.
Additionally, the company will be exhibiting at booth 905 promoting its line of Valeo silicon nitride spinal implants and the Taurus pedicle screw system. A
Podium Presentations
Enhanced Osseoconductivity via Endocytotic Formation of Silicon- and Nitrogen-Substituted Hydroxyapatite within the Osseous Tissue of a Retrieved Intervertebral Spinal Spacer
Presented by: Dr. Alex Gitelman, M.D.
Date: Wednesday, Oct. 25
Time: 2:05 p.m. EST
Session: Innovative Technologies Presentation
An Assessment of the Inherent Antimicrobial Resistance of Biomaterials Utilized in Spinal Fusion Surgery
Presented by: Dr. Craig Kuhns, M.D.
Date: Friday, Oct. 27
Time: 1:27 p.m. EST
Session: Abstract Presentations- Infection
Enhanced Bioactivity and Bacteriostasis of PEEK Polymers Through Incorporation of Silicon Nitride Particles
Presented by: Dr. Craig Kuhns, M.D.
Date: Friday, Oct. 27
Time: 1:33 p.m. EST
Session: Abstract Presentations- Infection
Amedica is focused on the development and application of spinal interbody implants made with medical-grade silicon nitride ceramic. Amedica markets spinal fusion products and is developing implants for other biomedical applications, such as wear- and corrosion-resistant hip and knee bearings, and dental implants. The company’s products are manufactured in its ISO 13485 certified manufacturing facility, and it has a partnership with Kyocera, one of the world’s largest ceramic manufacturers. Amedica’s U.S. Food and Drug Administration-cleared and CE-marked spine products are currently marketed in the United States and select markets in Europe and South America through its distributor network, and OEM and private label partnerships.
Amedica has had three podium presentations accepted by NASS that will be delivered by surgeon users of Amedica’s silicon nitride products. These presentations reflect the scientific and clinical advancements of Amedica’s innovative silicon nitride material. More specifically, the presentations will demonstrate silicon nitride’s innate bioactivity, osseoconductivity, and inherent antimicrobial properties.
Additionally, the company will be exhibiting at booth 905 promoting its line of Valeo silicon nitride spinal implants and the Taurus pedicle screw system. A
Podium Presentations
Enhanced Osseoconductivity via Endocytotic Formation of Silicon- and Nitrogen-Substituted Hydroxyapatite within the Osseous Tissue of a Retrieved Intervertebral Spinal Spacer
Presented by: Dr. Alex Gitelman, M.D.
Date: Wednesday, Oct. 25
Time: 2:05 p.m. EST
Session: Innovative Technologies Presentation
An Assessment of the Inherent Antimicrobial Resistance of Biomaterials Utilized in Spinal Fusion Surgery
Presented by: Dr. Craig Kuhns, M.D.
Date: Friday, Oct. 27
Time: 1:27 p.m. EST
Session: Abstract Presentations- Infection
Enhanced Bioactivity and Bacteriostasis of PEEK Polymers Through Incorporation of Silicon Nitride Particles
Presented by: Dr. Craig Kuhns, M.D.
Date: Friday, Oct. 27
Time: 1:33 p.m. EST
Session: Abstract Presentations- Infection
Amedica is focused on the development and application of spinal interbody implants made with medical-grade silicon nitride ceramic. Amedica markets spinal fusion products and is developing implants for other biomedical applications, such as wear- and corrosion-resistant hip and knee bearings, and dental implants. The company’s products are manufactured in its ISO 13485 certified manufacturing facility, and it has a partnership with Kyocera, one of the world’s largest ceramic manufacturers. Amedica’s U.S. Food and Drug Administration-cleared and CE-marked spine products are currently marketed in the United States and select markets in Europe and South America through its distributor network, and OEM and private label partnerships.